Glyceryl monooleate-coated bioadhesive hollow microspheres of riboflavin for improved gastroretentivity: Optimization and pharmacokinetics

Drug Delivery and Translational Research

Volumn 3, Issue 3, 2013, Pages 209-223

  Upadhyay, Mayank Shekhar ^a   Pathak, Kamla ^a  

^a NH 2   (India)

Author keywords

Bioadhesive hollow microspheres; Factorial design; Glyceryl monooleate; Pharmacokinetics; Riboflavin

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; GLYCEROL OLEATE; MICROSPHERE; RIBOFLAVIN;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; EMULSION; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY;

EID: 84877815703     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-013-0143-1     Document Type: Article

References (27)

1. Jusko WJ, Levy G. Absorption, metabolism and excretion of riboflavin 5′-phosphate in man. J Pharm Sci. 1967;56: 58-62.
2. Said HM, Ghishan FK, Greene HL, Hollander D. Developmental maturation of riboflavin intestinal transport in the rat. Pediatr Res. 1985;19: 1175-8.
3. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by emulsion solvent diffusion method. Eur J Pharm Biopharm. 2004;55: 297-304.
4. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro evaluation of floating and drug release behaviour of hollow microspheres (microballoons) prepared by emulsion solvent diffusion method. Eur J Pharm Biopharm. 2004;57: 235-43.
5. Yellanki SK, Nerella NK. Stomach specific drug delivery of riboflavin using floating alginate beads. Int J Pharm Pharm Sci. 2010;2(2): 160-3.
6. Singh AN, Pathak K. Development and evaluation of dual controlled release microballoons containing riboflavin and citric acid: in vitro and in vivo evaluation. J Microencapsul. 2011;28(5): 442-54.
7. Vasir J, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003;255: 13-32.
8. Yao H, Xu L, Han F, Che X, Dong Y, Wei M, et al. A novel riboflavin gastro-mucoadhesive delivery system based on ion-exchange fiber. Int J Pharm. 2008;364: 21-6.
9. Sallam A, Khalil E, Ibrahim H, Freij I. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate. Eur J Pharm Biopharm. 2002;53: 343-52.
10. Rowe RC, Shesky PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press; 2006. p. 185-7.
11. Neilson LS, Schubert L, Hansen J. Bioadhesive drug delivery systems: characterization of mucoadhesive properties of systems based on glyceryl monooleate and glycerol monolinoleate. Eur J Pharm Sci. 1998;6(9): 231-9.
12. Kawashima Y, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci. 1992;81: 135-40.
13. Bolton S. Pharmaceutical statistics: practical and clinical applications. New York: Marcel Dekker; 1990. p. 308-37.
14. Maharaj I, Campbell J, Nairn J. Simple rapid method for the preparation of enteric coated microspheres. J Pharm Sci. 1984;73: 39-42.
15. Aulton ME. Powder flow in pharmaceutics-the science of dosage form design. 2nd ed. London: Churchill Livingstone; 2002. p. 207-8.
16. Liu Z, Lu W, Qian L, Zhang X, Zeng P, Pan J. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin. J Control Release. 2005;102: 135-44.
17. Nyqvist H. Saturated salt solutions for maintaining specified relative humidities. Int J Pharm Tech Prod Mfr. 1983;4(2): 47-8.
18. Ali J, Hasan S, Ali M. Formulation and development of gastroretentive drug delivery system for ofloxacin. Exp Clin Pharmacol. 2006;28(7): 433-9.
19. Gattani YS, Kawtikwar PS, Sakarkar DM. Formulation and evaluation of gastro retentive multiparticulate drug delivery system of aceclofenac. Int J Chem Tech Res. 2009;1(1): 1-10.
20. Kumar MK, Shah MH, Ketkar A, Mahadik KR, Pardhkar A. Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. Int J Pharm. 2004;272: 151-60.
21. Engstrom S, Larsson K, Lindman B. Method of preparing controlled release preparations for biologically active materials. International patent application, PTC/SE83/00411 published 07. 06. 1984 under no. WO 84/02076.
22. Wyatt DM, Dorschel D. A cubic-phase delivery system composed of glyceryl monooleate and water for sustained release of water-soluble drugs. Pharm Technol. 1992;16: 116-30.
23. Lee J, Young SA, Kellaway IW. Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate. J Pharm Pharmacol. 2001;53: 629-36.
24. Liu Y, Zhang J, Gao Y, Zhu J. Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. Int J Pharm. 2011;413: 103-9.
25. Kagan L, Lapidot N, Afargan M, Kirmayer D, Moor E, Mardor Y, et al. Gastroretentive accordion pill: enhancement of riboflavin bioavailability in humans. J Control Release. 2006;113: 208-15.
26. Silverstein RM, Webster FX. Spectrometric identification of organic compounds. New York: Wiley; 2003. p. 71-111.
27. Zempleni J, Galloway JR, McCormick DB. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr. 1996;63: 54-66.